GPT and metabolic dysfunction-associated steatotic liver disease: Oral administration of δ-tocotrienol at 300 mg twice daily for 12 weeks showed greater efficacy than a placebo by decreasing oxidative stress markers including serum ALT, high-sensitivity C-reactive protein, and MDA in patients with nonalcoholic fatty liver disease [49].